Načítá se...
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study
To test the maximum tolerated dose (MTD) of a concomitant boost to the tumour bed for patients at high risk of recurrence treated with whole breast radiotherapy (RT). METHODS: Patients with breast cancer with pathological stage pT (1-2) and at least one risk factor for local recurrence such as N1 di...
Uloženo v:
| Vydáno v: | Br J Radiol |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The British Institute of Radiology.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6541174/ https://ncbi.nlm.nih.gov/pubmed/30433824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1259/bjr.20180169 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|